| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |